Success Metrics

Clinical Success Rate
72.7%

Based on 8 completed trials

Completion Rate
73%(8/11)
Active Trials
0(0%)
Results Posted
50%(4 trials)
Terminated
3(23%)

Phase Distribution

Ph not_applicable
9
69%
Ph phase_4
1
8%
Ph phase_2
2
15%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
9(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(8)
Terminated(3)
Other(1)

Detailed Status

Completed8
Terminated3
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
72.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (16.7%)
Phase 41 (8.3%)
N/A9 (75.0%)

Trials by Status

not_yet_recruiting18%
completed862%
terminated323%
unknown18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
OTHER
Total Trials
13